A comparison of open and minimally invasive surgery for hepatic and pancreatic resections using the Nationwide Inpatient Sample
- PMID: 25017135
- PMCID: PMC4316739
- DOI: 10.1016/j.surg.2014.03.046
A comparison of open and minimally invasive surgery for hepatic and pancreatic resections using the Nationwide Inpatient Sample
Abstract
Background: The use of minimally invasive surgery (MIS) techniques for pancreatic and liver operations remains ill defined. We sought to compare inpatient outcomes among patients undergoing open versus MIS pancreas and liver operations using a nationally representative cohort.
Methods: We queried the Nationwide Inpatient Sample database for all major pancreatic and hepatic resections performed between 2000 and 2011. Appropriate International Classification of Diseases, 9th Revision (ICD-9) coding modifiers for laparoscopy and robotic assist were used to categorize procedures as MIS. Demographics, comorbidities, and inpatient outcomes were compared between the open and MIS groups.
Results: A total of 65,033 resections were identified (pancreas, n = 36,195 [55.7%]; liver, n = 28,035 [43.1%]; combined pancreas and liver, n = 803 [1.2%]). The overwhelming majority of operations were performed open (n = 62,192, 95.6%), whereas 4.4% (n = 2,841) were MIS. The overall use of MIS increased from 2.3% in 2000 to 7.5% in 2011. Compared with patients undergoing an open operation, MIS patients were older and had a greater incidence of multiple comorbid conditions. After operation, the incidence of complications for MIS (pancreas, 35.4%; liver, 29.5%) was lower than for open (pancreas, 41.6%; liver, 33%) procedures (all P < .05) resulting in a shorter median length of stay (8 vs 7 days; P = .001) as well as a lower in-hospital mortality (5.1% vs 2.8%; P = .001).
Conclusion: During the last decade, the number of MIS pancreatic and hepatic operations has increased, with nearly 1 in 13 HPB cases now being performed via an MIS approach. Despite MIS patients tending to have more preoperative medical comorbidities, postoperative morbidity, mortality, and duration of stay compared favorably with open surgery.
Copyright © 2014 Mosby, Inc. All rights reserved.
Figures
Similar articles
-
National Trends in Postoperative Outcomes and Cost Comparing Minimally Invasive Versus Open Liver and Pancreatic Surgery.J Gastrointest Surg. 2016 Nov;20(11):1836-1843. doi: 10.1007/s11605-016-3267-z. Epub 2016 Sep 9. J Gastrointest Surg. 2016. PMID: 27613735
-
A Comparison of Open and Minimally Invasive Surgery for Hepatic and Pancreatic Resections Among the Medicare Population.J Gastrointest Surg. 2018 Dec;22(12):2088-2096. doi: 10.1007/s11605-018-3883-x. Epub 2018 Jul 23. J Gastrointest Surg. 2018. PMID: 30039449
-
Impact of shifting from laparoscopic to robotic surgery during 600 minimally invasive pancreatic and liver resections.Surg Endosc. 2023 Apr;37(4):2659-2672. doi: 10.1007/s00464-022-09735-4. Epub 2022 Nov 18. Surg Endosc. 2023. PMID: 36401105 Free PMC article.
-
[Hepatic and pancreatic laparoscopic surgery].An Sist Sanit Navar. 2005;28 Suppl 3:51-9. An Sist Sanit Navar. 2005. PMID: 16511579 Review. Spanish.
-
Pancreas-related complications following gastrectomy: systematic review and meta-analysis of open versus minimally invasive surgery.Surg Endosc. 2017 Nov;31(11):4346-4356. doi: 10.1007/s00464-017-5507-z. Epub 2017 Apr 4. Surg Endosc. 2017. PMID: 28378074 Review.
Cited by
-
Combined impact of local anaesthetic infiltration through wound catheter and epidural analgesia following surgical hepatectomy: a meta-analysis.Wideochir Inne Tech Maloinwazyjne. 2024 Mar;19(1):25-31. doi: 10.5114/wiitm.2024.135810. Epub 2024 Feb 27. Wideochir Inne Tech Maloinwazyjne. 2024. PMID: 38974756 Free PMC article.
-
Risk factors and outcomes for cholangitis after hepatic resection.Langenbecks Arch Surg. 2023 Jun 17;408(1):236. doi: 10.1007/s00423-023-02769-9. Langenbecks Arch Surg. 2023. PMID: 37329363
-
Remote and asynchronous training network: from a SAGES grant to an eight-country remote laparoscopic simulation training program.Surg Endosc. 2023 Feb;37(2):1458-1465. doi: 10.1007/s00464-022-09386-5. Epub 2022 Jun 28. Surg Endosc. 2023. PMID: 35764838
-
Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma.Hepat Med. 2021 Nov 2;13:93-104. doi: 10.2147/HMER.S278136. eCollection 2021. Hepat Med. 2021. PMID: 34754247 Free PMC article. Review.
-
The Role of Surgical Resection and Liver Transplantation for the Treatment of Intrahepatic Cholangiocarcinoma.J Clin Med. 2021 May 30;10(11):2428. doi: 10.3390/jcm10112428. J Clin Med. 2021. PMID: 34070772 Free PMC article. Review.
References
-
- Thakur V, Schlachta CM, Jayaraman S. Minilaparoscopic versus conventional laparoscopic cholecystectomy a systematic review and meta-analysis. Ann Surg. 2011;253:244–258. - PubMed
-
- Levy BF, Tilney HS, Dowson HM, Rockall TA. A systematic review of postoperative analgesia following laparoscopic colorectal surgery. Colorectal Dis. 2010;12:5–15. - PubMed
-
- Kendrick ML. Laparoscopic and robotic resection for pancreatic cancer. Cancer J. 2012;18:571–576. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
